These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 20512891

  • 21. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.
    Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G, Trachtenberg J.
    AJR Am J Roentgenol; 2007 Aug; 189(2):323-8. PubMed ID: 17646457
    [Abstract] [Full Text] [Related]

  • 22. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
    Song N, Wang T, Zhang D, Wang Z, Zhang SR, Yu J, Cai L, Ma AL, Zhang Q, Chen ZQ.
    Zhonghua Yi Xue Za Zhi; 2022 Apr 19; 102(15):1093-1099. PubMed ID: 35436808
    [Abstract] [Full Text] [Related]

  • 23. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy.
    Verma S, Rajesh A, Morales H, Lemen L, Bills G, Delworth M, Gaitonde K, Ying J, Samartunga R, Lamba M.
    AJR Am J Roentgenol; 2011 Feb 19; 196(2):374-81. PubMed ID: 21257890
    [Abstract] [Full Text] [Related]

  • 24. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK, Park BK, Lee HM, Kwon GY.
    Invest Radiol; 2007 Dec 19; 42(12):842-7. PubMed ID: 18007156
    [Abstract] [Full Text] [Related]

  • 25. Anterior Prostate Cancer: Diagnostic Performance of T2-Weighted MRI and an Apparent Diffusion Coefficient Map.
    Shinmoto H, Tamura C, Soga S, Okamura T, Horiguchi A, Asano T, Kaji T.
    AJR Am J Roentgenol; 2015 Aug 19; 205(2):W185-92. PubMed ID: 26204306
    [Abstract] [Full Text] [Related]

  • 26. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
    Hambrock T, Somford DM, Huisman HJ, van Oort IM, Witjes JA, Hulsbergen-van de Kaa CA, Scheenen T, Barentsz JO.
    Radiology; 2011 May 19; 259(2):453-61. PubMed ID: 21502392
    [Abstract] [Full Text] [Related]

  • 27. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H, Kizilgöz V, Tatar IG, Damar C, Ugan AR, Paker I, Hekimoğlu B.
    J Comput Assist Tomogr; 2012 May 19; 36(1):30-45. PubMed ID: 22261768
    [Abstract] [Full Text] [Related]

  • 28. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
    Nowak J, Malzahn U, Baur AD, Reichelt U, Franiel T, Hamm B, Durmus T.
    Acta Radiol; 2016 Jan 19; 57(1):107-14. PubMed ID: 25505225
    [Abstract] [Full Text] [Related]

  • 29. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
    Riches SF, Payne GS, Morgan VA, Sandhu S, Fisher C, Germuska M, Collins DJ, Thompson A, deSouza NM.
    AJR Am J Roentgenol; 2009 Dec 19; 193(6):1583-91. PubMed ID: 19933651
    [Abstract] [Full Text] [Related]

  • 30. Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T.
    Thörmer G, Otto J, Horn LC, Garnov N, Do M, Franz T, Stolzenburg JU, Moche M, Kahn T, Busse H.
    Acta Radiol; 2015 Jan 19; 56(1):121-8. PubMed ID: 24504488
    [Abstract] [Full Text] [Related]

  • 31. Exponential apparent diffusion coefficient in evaluating prostate cancer at 3 T: preliminary experience.
    Park SY, Kim CK, Park JJ, Park BK.
    Br J Radiol; 2016 Jan 19; 89(1058):20150470. PubMed ID: 26653866
    [Abstract] [Full Text] [Related]

  • 32. Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study.
    Peng Y, Jiang Y, Yang C, Brown JB, Antic T, Sethi I, Schmid-Tannwald C, Giger ML, Eggener SE, Oto A.
    Radiology; 2013 Jun 19; 267(3):787-96. PubMed ID: 23392430
    [Abstract] [Full Text] [Related]

  • 33. Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
    Naiki T, Okamura T, Nagata D, Mori Y, Kawai N, Ogawa K, Akita H, Hashimoto Y, Tozawa K, Kohri K.
    Asian Pac J Cancer Prev; 2011 Jun 19; 12(4):909-13. PubMed ID: 21790224
    [Abstract] [Full Text] [Related]

  • 34. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers.
    Langer DL, van der Kwast TH, Evans AJ, Sun L, Yaffe MJ, Trachtenberg J, Haider MA.
    Radiology; 2008 Dec 19; 249(3):900-8. PubMed ID: 19011187
    [Abstract] [Full Text] [Related]

  • 35. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
    Rosenkrantz AB, Chandarana H, Gilet A, Deng FM, Babb JS, Melamed J, Taneja SS.
    J Magn Reson Imaging; 2013 Aug 19; 38(2):312-9. PubMed ID: 23238968
    [Abstract] [Full Text] [Related]

  • 36. High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3 T.
    Wang X, Qian Y, Liu B, Cao L, Fan Y, Zhang JJ, Yu Y.
    Clin Radiol; 2014 Nov 19; 69(11):1165-70. PubMed ID: 25182363
    [Abstract] [Full Text] [Related]

  • 37. Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T.
    Bogner W, Pinker K, Zaric O, Baltzer P, Minarikova L, Porter D, Bago-Horvath Z, Dubsky P, Helbich TH, Trattnig S, Gruber S.
    Radiology; 2015 Jan 19; 274(1):74-84. PubMed ID: 25341078
    [Abstract] [Full Text] [Related]

  • 38. Diffusion tensor imaging of prostate at 3.0 Tesla.
    Li C, Chen M, Li S, Zhao X, Zhang C, Liu M, Zhou C.
    Acta Radiol; 2011 Sep 01; 52(7):813-7. PubMed ID: 21586608
    [Abstract] [Full Text] [Related]

  • 39. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
    Reinsberg SA, Payne GS, Riches SF, Ashley S, Brewster JM, Morgan VA, deSouza NM.
    AJR Am J Roentgenol; 2007 Jan 01; 188(1):91-8. PubMed ID: 17179350
    [Abstract] [Full Text] [Related]

  • 40. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM, Heerschap A, Jensen LR, Tessem MB, Schweder GJ, Goa PE, Viset T, Angelsen A, Gribbestad IS.
    Invest Radiol; 2012 Nov 01; 47(11):624-33. PubMed ID: 23011187
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.